Liabilities / Assets
83rd percentile
Higher debt load relative to assets than 83% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.76x
Liabilities / Revenue
86th percentile
Higher debt load relative to revenue than 86% of similar nonprofits.
Net Margin
10th percentile
Higher net margin than 10% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
6th percentile
Faster asset growth than 6% of similar nonprofits.
Revenue Growth
14th percentile
Faster revenue growth than 14% of similar nonprofits.
Balance Sheet
Assets
Down$24,577,322
Down $4,049,370 (-14%) from 2011
Net Assets
Down$5,899,923
Down $2,947,000 (-33%) from 2011
Liabilities
Down$18,677,399
Down $1,102,370 (-5.6%) from 2011
Revenue And Expenses
Revenue
Down$9,699,975
Down $2,761,604 (-22%) from 2011
Expenses
Down$12,473,646
Down $1,322,425 (-9.6%) from 2011
Net Income
Down-$2,773,671
Down $1,439,179 (-108%) from 2011
Historical Trend
Filing Detail Status
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jul 1, 2011 to Jun 30, 2012
Mission and Program Overview
Mission
Boston biomedical research institute is an independent, not-for-profit institution dedicated to basic biomedical research to promote the understanding, treatment and prevention of cancer, cardiovasular, and neuromuscular degenerative diseases such as alzheimer's and muscular dystrophy, and to the training of research scientists.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $24,577,322
- Liabilities
- $18,677,399
- Net assets
- $5,899,923
- Revenue
- $9,699,975
- Expenses
- $12,473,646
- Net income
- -$2,773,671